AFL vs TECH · P/E 14, rev $18.93B vs P/E 65, rev $1.22B
Aflac Incorporated (AFL) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AFL revenue for 2024-12-31 was $18.93B. Net income was $5.44B. Revenue was up 401.1% from 2023-12-31 to 2024-12-31. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AFL currently screens at market cap $60.18B and trailing P/E 13.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AFL and TECH stock pages for the full models.
Not investment advice.